US Patent 7244713 Nucleoside compounds for treating viral infections
Patent 7244713 was granted and assigned to Genelabs Technologies on July, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Christopher D. Roberts0
Jesse D. Keicher0
Natalia B. Dyatkina0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+216 characters)
Article
Patent abstract
Disclosed are compounds, compositions and methods for treating viral infections caused by a flaviviridae family virus, such as hepatitis C virus. Such compounds are represented by Formula I as follows:
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07244713 Nucleoside compounds for treating viral infections US Patent 7244713 Nucleoside compounds for treating viral infections
Infobox
Patent Number
072447130
Patent Number
72447130
Edits on 5 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072447130
Date of Patent
July 17, 2007
0Patent Application Number
109714770
Date Filed
October 21, 2004
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 21 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07244713 Nucleoside compounds for treating viral infections
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07244713
Date of patent
July 17, 2007
Patent application number
10971477
Date Filed
October 21, 2004
Patent primary examiner
Find more entities like US Patent 7244713 Nucleoside compounds for treating viral infections
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
